UNITY BIOTECHNOLOGY INC (UBX)       2.74  -0.19 (-6.48%)

2.74  -0.19 (-6.48%)

US91381U2006 - Common Stock

Buy % Consensus

Analysts have set a mean price target of 34.51. This target is 1159.49% above the current price.
UBX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about UBX.
In the previous month the buy percentage consensus was at a similar level.
UBX was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 2.7410.1013.7734.51126.00 - 268.61% 402.55% 1,159.49% 4,498.54%

Up and Down Grades

Date Firm Action Rating
2022-11-16 Mizuho Maintains Buy
2022-11-09 HC Wainwright & Co. Maintains Buy
2022-11-02 Wedbush Maintains Outperform
2022-08-16 Mizuho Maintains Buy
2022-08-15 Citigroup Maintains Buy
2022-05-17 Citigroup Maintains Buy
2022-01-04 Roth Capital Upgrade Neutral -> Buy
2021-11-10 Mizuho Upgrade Neutral -> Buy
2021-06-28 Citigroup Upgrade Sell -> Buy
2021-06-07 HC Wainwright & Co. Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA